ARLENE MARTINEZ-DELIO: Open Payments
NPI 1215945365 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 90 payments from 15 companies in 2025. Trend: 2023 $2,876 · 2024 $2,267 · 2025 $1,948
Food & beverage: $1,948
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $577 |
| Neurocrine BioSciences, Inc. | 11 | $222 |
| Lundbeck LLC | 7 | $185 |
| Corium, LLC | 12 | $181 |
| ABBVIE INC. | 9 | $151 |
| Collegium Pharmaceutical, Inc. | 7 | $128 |
| Noven Therapeutics, LLC | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Alkermes, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
Products named: HETLIOZ, INGREZZA, FANAPT, REXULTI, Azstarys, VRAYLAR, Jornay PM, Xelstrym.
Industry payments across FL — which companies pay providers there.
